Cable Hill Partners LLC now owns 2,711 shares of the company's stock worth $177,000 after buying an additional 186 shares during the period.
AbbVie Inc.is a research-based biopharmaceutical company. The stock rose 0.13% or $0.09 reaching $70 per share. AbbVie Inc. (NYSE:ABBV), at its latest closing price of $70.44, it has a price-to-book ratio of 22.43, compared to an industry average at 4.78. It has underperformed by 6.07% the S&P500. Community Bank N.A. increased its position in AbbVie by 1.6% in the first quarter. The number of shares now owned by investors are 1.62 bln. Toth Financial Advisory Corp now owns 61,012 shares of the company's stock valued at $3,976,000 after buying an additional 1,536 shares during the last quarter. (ABBV) has the trading volume of 8 Million shares with the average trading volume of 6050 shares. (NASDAQ:ISBC) has risen 13.02% since July 31, 2016 and is uptrending. It has underperformed by 16.70% the S&P500.
Since February 28, 2017, it had 0 buys, and 10 insider sales for $28.02 million activity. Deutsche Bank AG increased their target price on AbbVie from $64.00 to $65.00 and gave the company a "hold" rating in a research report on Friday, April 28th. Also, EVP Carlos Alban sold 45,800 shares of the firm's stock in a transaction dated Wednesday, June 14th.
The analysts offering 12 month price targets for AbbVie Inc. have a median target of $72.5, with a high estimate of $95 and a low estimate of $60.
Korea Investment Corp says it raised its stake in AbbVie Inc.by 2.3% in the last quarter. BNP Paribas Securities Services will calculate the average sale price of the AbbVie shares and will transfer the sale proceeds to the AbbVie selling shareholders once it receives the funds. Lastly, MML clients Services bought a fresh stake in stocks of AbbVie throughout the Q4 valued $272,000. hedge fund investors and investment firms has an ownership of 68.00% of the firms stock. It also reduced Vanguard Specialized Portfol (VIG) stake by 5,000 shares and now owns 11,355 shares. Praxair Inc (NYSE:PX) was reduced too. AbbVie has a one year low of $55.06 and a one year high of $75.04. Therefore 39% are positive. On average, analysts anticipate that AbbVie will post $5.53 EPS for the current year. Atlantic Securities initiated it with "Neutral" rating and $59 target in Friday, December 18 report. The correct version of this news story can be read at https://www.themarketsdaily.com/2017/08/01/tarbox-group-inc-has-3497000-stake-in-abbvie-inc-abbv-updated-updated.html. The firm earned "Mkt Perform" rating on Tuesday, October 18 by Leerink Swann. Morgan Stanley upgraded AbbVie Inc (NYSE:ABBV) on Monday, November 2 to "Overweight" rating. The firm has "Buy" rating given on Thursday, May 25 by Jefferies. The dividend payment will be $0.640 per share for the quarter or $2.56 annualized.
05/17/2017 - AbbVie Inc. had its " rating reiterated by analysts at BMO Capital Markets.
It is down 0.00% since August 1, 2016 and is. Its down 1.48, from 2.57 in 2016Q3.
Other large investors have also modified their holdings of the company. 22 funds opened positions while 63 raised stakes. Bollard Gp Limited Liability Corporation invested in 0.02% or 3,725 shares. Kanawha Mgmt Limited Liability Company has 174,255 shares for 1.83% of their portfolio. Swiss Bancorp reported 137,000 shares. Segall Bryant & Hamill Ltd Company holds 0.39% or 249,215 shares in its portfolio. Factory Mutual Insurance Commerce holds 0.31% or 426,100 shares. The Illinois-based Inspirion Wealth Advisors Llc has invested 8.17% in the stock. 153,558 are owned by Asset. Abbvie Inc. Com now has $112.11 billion valuation. 4,040 were reported by Grimes. Moreover, Blackrock Japan Limited has 0.47% invested in AbbVie Inc (NYSE:ABBV). Columbia Pacific Advisors Llc owns 374,552 shares or 13.16% of their USA portfolio. Eight research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. Therefore 67% are positive. Goldman Sachs maintained the stock with "Buy" rating in Friday, March 10 report. The stock of Investors Bancorp, Inc. The rating was downgraded by Barclays Capital on Tuesday, December 6 to "Underweight". The rating was downgraded by Compass Point to "Sell" on Friday, January 29. The firm earned "Neutral" rating on Tuesday, July 28 by Bank of America. That puts total institutional holdings at 1,095,831,683 shares, according to SEC filings. 235.73 million shares or 2.04% less from 240.63 million shares in 2016Q3 were reported. Ahl Partners Llp has invested 0.14% in Investors Bancorp, Inc. Visionary Asset Management accumulated 48,853 shares. Mcrae Capital holds 31,290 shares. Great Lakes Advsrs Ltd holds 0.16% or 449,968 shares in its portfolio. Park Avenue Llc stated it has 3,710 shares or 0.11% of all its holdings. Ahl Ltd Liability Partnership holds 151,884 shares. Alyeska Lp invested in 0.04% or 424,879 shares.
09/01/2016 - Raymond James began new coverage on AbbVie Inc. giving the company a " rating. Pnc Fincl Svcs Group Inc has invested 0% in Investors Bancorp, Inc. Wealthtrust holds 1,465 shares. Godshalk Welsh Capital Management accumulated 0.66% or 10,358 shares. Another trade for 20,000 shares valued at $405,668 was made by JOHNSON MARIANNE BOYD on Thursday, February 16. Mechanics Financial Bank Department owns 5,265 shares.